A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder

NCT00402584 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
304
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Abbott